Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 3 53-3, 2003, Pages

  Wright, John W ^a   Tamura Myers, Elizabeth ^a   Wilson, Wendy L ^a   Roques, Bernard P ^b   Llorens Cortes, Catherine ^c   Speth, Robert C ^a   Harding, Joseph W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b CNRS   (France)

^c l'alimentation et l'Environnement   (France)

Author keywords

Blood pressure; D Arg1Angiotensin III; N Asp1Angiotensin II

Indexed keywords

2 AMINO 4 METHYLSULFONYLBUTANETHIOL; 3 AMINO 4 THIOBUTYLSULFONATE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [1 DEXTRO ARGININE]; ANGIOTENSIN II [1 DEXTRO ASPARTIC ACID]; ANGIOTENSIN III; BUTANE; EC 33; ENZYME INHIBITOR; GLUTAMYL AMINOPEPTIDASE; LOSARTAN; MICROSOMAL AMINOPEPTIDASE; PC 18; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG POTENTIATION; DRUG RESPONSE; ENZYME INHIBITION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

EID: 0037343289     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00326.2002     Document Type: Article

References (55)

1. Abhold RH and Harding JW. Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain. J Pharmacol Exp Ther 245: 171-177, 1988.
2. Allen AM, MacGregor DP, McKinley MJ, and Mendelsohn FA. Angiotensin II receptors in the human brain. Regul Pept 79: 1-7, 1999.
3. 1 receptors. Am J Hypertens 13: 31S-38S, 2000.
4. Batt CM, Klein EW, Harding JW, and Wright JW. Pressor responses to amastatin, bestatin and plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran. Brain Res Bull 21: 731-735, 1988.
5. Blair-West JR, Carey KD, Denton DA, Madden LJ, Weisinger RS, and Shade RE. Possible contribution of brain angiotensin III to ingestive behaviors in baboons. Am J Physiol Regul Integr Comp Physiol 281: R1633-R1636, 2001.
6. Chauvel EN, Coric P, Llorens-Cortes C, Wilk S, Roques BP, and Fournie-Zaluski MC. Differential inhibition of aminopeptidase A and aminopeptidase N by new β-amino thiols. J Med Chem 37: 2950-2957, 1994.
7. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, and Timmermans PB. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165: 196-203, 1989.
8. 1B receptors revealed by gene targeting (Abstract). Hypertension 32: 595, 1998.
9. Davisson RL, Oliverio MK, Coffman TM, and Sigmund CD. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 106: 103-106, 2000.
10. De Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
11. De Gasparo M, Husain A, Alexander W, Cat KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, and Timmermans PB. Proposed update of angiotensin receptor nomenclature. Hypertension 25: 924-939, 1995.
12. 2 receptor: fact, fancy and fantasy. Regul Pept 81: 11-24, 1999.
13. 125I-angiotensins in the cerebroventricles of the rat. Brain Res 448: 366-372, 1988.
14. Elton TS, Stephan CC, Taylor GR, Kimball MG, Martin MM, Durand JN, and Oparil S. Isolation of two distinct type I angiotensin II receptor genes. Biochem Biophys Res Commun 184: 1067-1073, 1992.
15. Felix D and Schlegel W. Angiotensin receptive neurons in the subfornical organ-structure-activity relations. Brain Res 149: 107-116, 1978.
16. Fink GD and Bruner CA. Hypertension during chronic peripheral and central infusion of angiotensin III. Am J Physiol Endocrinol Metab 249: E201-E208, 1985.
17. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 78: 583-686, 1998.
18. Fournie-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Maldonado R, and Roques BP. Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J Med Chem 35: 1259-1266, 1992.
19. Gallinat S, Busche S, Raizada MK, and Sumners C. The angiotensin II type 2 receptor; an enigma with multiple variations. Am J Physiol Endocrinol Metab 278: E357-E374, 2000.
20. Harding JW and Felix D. Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res 410: 130-134, 1987.
21. Harding JW, Jensen LL, Hanesworth KQ, Roberts KA, Page TD, and Wright JW. Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. Am J Physiol Renal Fluid Electrolyte Physiol 262: F17-F23, 1992.
22. 125I-angiotensins in rat. J Neurochem 46: 1292-1297, 1986.
23. Iwai N and Inagami T. Identification of two subtypes in the rat type I angiotensin receptor. FEBS Lett 298: 257-260, 1992.
24. Iwai N, Yamano Y, Chaki S, Konishi F, Bardhan S, Tibbets C, Sasaki K, Hasegawu K, Matsuda Y, and Inagami T. Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun 177: 299-304, 1991.
25. Jensen LL, Harding JW, and Wright JW. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains. Brain Res 490: 48-55, 1989.
26. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, and Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268: 24543-24546, 1993.
27. Lenkei Z, Palkovits M, Corvol P, and Llorens-Cortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18: 383-439, 1997.
28. Moeller I, Allen AM, Chai SY, Zhuo J, and Mendelsohn TA. Bioactive angiotensin peptides. J Hum Hypertens 12: 289-293, 1998.
29. Moore GJ. Angiotensin and bradykinin receptors. In: Comprehensive Medicinal Chemistry, edited by Emmett JD. Oxford, UK: Elsevier/Pergamon, 1990, vol. 3, p. 961-980.
30. Moore GJ. Designing peptide mimetics. Trends Pharmacol Sci 15: 124-129, 1994.
31. Moore GJ, Smith JR, Baylis BW, and Matsoukas JM. Design and pharmacology of peptide mimetics. In: Advances in Pharmacology. Orlando, FL: Academic, 1995, vol. 33, p, 91-141.
32. Mukoyama M, Nakajima M, Horiuchi M, Susamura H, Pratt RE, and Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268: 24539-24542, 1993.
33. Murphy TJ, Alexander RW, Griendling KK, Runge MS, and Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-236, 1991.
34. Reaux A, de Mota N, Zini S, Cadel S, Fournie-Zaluski MC, Roques BP, Corvol P, and Llorens-Cortes C. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology 69: 370-376, 1999.
35. Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvo P, and Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 96: 13415-13420, 1999.
36. Reaux A, Fournie-Zaluski CF, and Llorens-Cortes C. Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endoc Metab 12: 157-162, 2001.
37. Saavedra JM. Emerging features of brain angiotensin receptors. Regul Pept 85: 31-45, 1999.
38. Sandberg K, Ji H, Clark A, Shapira H, and Catt K. Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem 267: 9455-9458, 1992.
39. Song L, Wilk S, and Healy DP. Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Res 744: 1-6, 1997.
40. Speth RC, Smith MS, and Grove KL. Brain angiotensinergic mediation of enhanced water consumption in lactating rats. Am J Physiol Regul Integr Comp Physiol 282: R695-R701, 2002.
41. Stone EA. Improved polyethylene intracerebroventricular cannulas for rats. Physiol Behav 20: 657-659, 1978.
42. Sullivan MJ, Harding JW, and Wright JW. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses. Brain Res 456: 249-253, 1988.
43. Thomas WG. Regulation of angiotensin II type 1 (AT1) receptor function. Regul Pept 79: 9-23, 1999.
44. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, and Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
45. Unger T. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens 17: 1775-1786, 1999.
46. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Hohle S, Meffert S, Stoll M, Stroth U, and Zhu YZ. Angiotensin receptors. J Hypertens 14: S95-S103, 1996.
47. Whitebread S, Mele M, Kamber B, and de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163: 284-288, 1989.
48. 4 and their functions. Regul Pept 59: 269-295, 1995.
49. Wright JW and Harding JW. Important roles for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev 25: 96-124, 1997.
50. Wright JW, Jensen LL, Roberts KA, Sardinia MF, and Harding JW. Structure-function analyses of brain angiotensin control of pressor action in rats. Am J Physiol Regul Integr Comp Physiol 257: R1551-R1557, 1989.
51. Wright JW, Morseth SC, Abhold RH, and Harding JW. Pressor action and dipsogenicity induced by angiotensin II and III in rats. Am J Physiol Regul Integr Comp Physiol 249: R514-R521, 1985.
52. Wright JW, Quirk WS, Hanesworth JM, and Harding JW. Influence of aminopeptidase inhbitiors on brain angiotensin metabolism and drinking in rats. Brain Res 441: 215-220, 1988.
53. 1 angiotensin II as a pressor agent in rats. Brain Res 514: 5-10, 1990.
54. Zhu GQ, Patel KP, Zucker IH, and Wang W. Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am J Physiol Heart Circ Physiol 282: H2039-H2045, 2002.
55. Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P, and Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predomiant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93: 11968-11973, 1996.